Preclinical pharmacological profile of the selective 5-HT1<sub>F</sub> receptor agonist lasmiditan. A comment.
- Published in:
- Cephalalgia, 2010, v. 30, n. 10, p. 1159, doi. 10.1177/0333102411406753
- By:
- Publication type:
- Article
Works matching IS 03331024 AND DT 2010 AND VI 30 AND IP 10
Results: 19
1
2
President’s Corner October 2010.
- Published in:
- Cephalalgia, 2010, v. 30, n. 10, p. 1280, doi. 10.1177/0333102410382829
- By:
- Publication type:
- Article
3
5-Hydroxyptryptamine 1F (5-HT1F) receptor agonism. A possible new treatment principle for acute migraine attacks.
- Published in:
- Cephalalgia, 2010, v. 30, n. 10, p. 1157, doi. 10.1177/0333102410377671
- By:
- Publication type:
- Article
4
Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan – A randomised proof-of-concept trial.
- Published in:
- Cephalalgia, 2010, v. 30, n. 10, p. 1170, doi. 10.1177/0333102410375512
- By:
- Publication type:
- Article
5
The classification of chronic headache: Room for further improvement?
- Published in:
- 2010
- By:
- Publication type:
- Opinion
6
Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan.
- Published in:
- Cephalalgia, 2010, v. 30, n. 10, p. 1159, doi. 10.1177/0333102410370873
- By:
- Publication type:
- Article
7
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura.
- Published in:
- Cephalalgia, 2010, v. 30, n. 10, p. 1179, doi. 10.1177/0333102410368444
- By:
- Publication type:
- Article
8
Reversible cerebral vasoconstriction syndrome in two patients with a carotid glomus tumour.
- Published in:
- Cephalalgia, 2010, v. 30, n. 10, p. 1271, doi. 10.1177/0333102410365107
- By:
- Publication type:
- Article
9
Neurophysiological markers of central sensitisation in the trigeminal pathway and their modulation by the cyclo-oxygenase inhibitor ketorolac.
- Published in:
- Cephalalgia, 2010, v. 30, n. 10, p. 1241, doi. 10.1177/0333102410365104
- By:
- Publication type:
- Article
10
Calcitonin gene related peptide (CGRP)–provoked migraine-like attacks.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
11
Inhibition of nitric oxide synthases prevents and reverses α,β-meATP-induced neck muscle nociception in mice.
- Published in:
- Cephalalgia, 2010, v. 30, n. 10, p. 1225, doi. 10.1177/0333102410361538
- By:
- Publication type:
- Article
12
Consistency of response to sumatriptan/naproxen sodium in a placebo-controlled cross-over study.
- Published in:
- 2010
- By:
- Publication type:
- Letter
13
Stress and tension-type headache mechanisms.
- Published in:
- Cephalalgia, 2010, v. 30, n. 10, p. 1250, doi. 10.1177/0333102410362927
- By:
- Publication type:
- Article
14
Does single cortical spreading depression elicit pain behaviour in freely moving rats?
- Published in:
- Cephalalgia, 2010, v. 30, n. 10, p. 1195, doi. 10.1177/0333102409360828
- By:
- Publication type:
- Article
15
Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries.
- Published in:
- Cephalalgia, 2010, v. 30, n. 10, p. 1233, doi. 10.1177/0333102410362122
- By:
- Publication type:
- Article
16
Response to Seshia S et al.: The classification of chronic headache: Room for further improvement? Chronic headache classification.
- Published in:
- 2010
- By:
- Publication type:
- Letter
17
Predictors of outcome of the treatment programme in a multidisciplinary headache centre.
- Published in:
- Cephalalgia, 2010, v. 30, n. 10, p. 1214, doi. 10.1177/0333102410361403
- By:
- Publication type:
- Article
18
Menstrual and nonmenstrual migraines differ in women with menstrually-related migraine.
- Published in:
- Cephalalgia, 2010, v. 30, n. 10, p. 1187, doi. 10.1177/0333102409359315
- By:
- Publication type:
- Article
19
Clinical determinants of migraine preventive treatment: Contribution of SMILE, an observational survey of primary care migraine management in France.
- Published in:
- Cephalalgia, 2010, v. 30, n. 10, p. 1207, doi. 10.1177/0333102409355661
- By:
- Publication type:
- Article